Cat. #162366

EN1 expressing Flp-In™ T-REx™ 293 cell line

Name: EN1 expressing Flp-In™ T-REx™ 293 cell line
SKU: 162366
Availability: InStock

Cat. #: 162366

Organism: Human

Tissue: Kidney

Disease: Salivary gland tumours

Model: Genetically modified cell line

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Enquire or request a quote

Contributor

Inventor: Markku Varjosalo

Institute: University of Helsinki

Primary Citation: Kinnunen et al. (2023). Cancers (Basel). 15(17):4246. PMID: 37686522

Tool Details

Handling

References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

Name: EN1 expressing Flp-In™ T-REx™ 293 cell line
Cancer type: Breast cancer
Parental cell: Flp-In™ T-REx™ 293
Organism: Human
Tissue: Kidney
Disease: Salivary gland tumours
Model: Genetically modified cell line
Description: Flp-In™ T-REx™ 293 cells expressing ETV6-NTRK3 (EN) variant 1 (EN1) oncofusion
Biosafety level: 2

Handling

Format: Frozen
Growth medium: Low-glucose DMEM pH 7.4 supplemented with penicillin–streptomycin and 10% FBS
Atmosphere: 5% CO2
Shipping conditions: Dry ice
Storage conditions: Liquid Nitrogen
Cultured in antibiotics: Yes, penicillin/streptomycin

References

Kinnunen et al. (2023). Cancers (Basel). 15(17):4246. PMID: 37686522